ClinicalTrials.Veeva

Menu

Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment (EPILOGUE)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Completed

Conditions

COVID-19
Addiction, Substance

Study type

Observational

Funder types

Other

Identifiers

NCT04343339
RECHMPL20_0195

Details and patient eligibility

About

The current containment linked to COVID-19 will have consequences for people suffering from addiction and there is a risk of overdoses when the containment ends. So the investigators hypothesize that this health crisis is an opportunity to develop risk reduction and access to care for vulnerable people who lives with an addiction.

The main objective of this study is to describe the changes in the psychoactive substances consumption during the containment in people suffering from addiction. The secondary objectives are to describe the evolution at 1 month from the end of the containment of problematic consumption and the level of access to care of these users

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • >18 years
  • Accept study
  • live with an addiction

Exclusion criteria

  • not being able to answer the questionnaire

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems